Skip to main content

Table 1 Baseline clinical data of 120 patients with advanced HCC

From: High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma

Presentation

Cases (%)

Gender

 

  male

106(88.3%)

Age(yrs), median (range)

48 (28–72)

ECOG PS

 

  0

25(20.8%)

  1

55(45.8%)

  2

40(33.3%)

HCC differentiation

 

  well

20(16.7%)

  moderately

50(41.7%)

  poorly

50(41.7%)

HCC diameter (cm),median (range)

6 (2.4-12.6)

Tumor number

 

  1

67(55.8%)

  2

33(27.5%)

  3

20(16.7%)

Invasion to portal vein

 

  Branch

71(59.2%)

  Trunk

49(40.8%)

HBV DNA

 

  Positive

76(63.3%)

Child-Pugh class

 

  A

58(48.3%)

  B

62(51.7%)

AFP(ng/ml), median (range)

1368 (7–20000)

  1. ECOG: Eastern Cooperative Oncology Group;
  2. HBV: hepatitis B virus; AFP: alfa-fetoprotein.